Cargando…

Increased pathogenicity of pneumococcal serotype 1 is driven by rapid autolysis and release of pneumolysin

Streptococcus pneumoniae serotype 1 is the predominant cause of invasive pneumococcal disease in sub-Saharan Africa, but the mechanism behind its increased invasiveness is not well understood. Here, we use mouse models of lung infection to identify virulence factors associated with severe bacteraemi...

Descripción completa

Detalles Bibliográficos
Autores principales: Jacques, Laura C., Panagiotou, Stavros, Baltazar, Murielle, Senghore, Madikay, Khandaker, Shadia, Xu, Rong, Bricio-Moreno, Laura, Yang, Marie, Dowson, Christopher G., Everett, Dean B., Neill, Daniel R., Kadioglu, Aras
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7170840/
https://www.ncbi.nlm.nih.gov/pubmed/32312961
http://dx.doi.org/10.1038/s41467-020-15751-6
_version_ 1783523956450394112
author Jacques, Laura C.
Panagiotou, Stavros
Baltazar, Murielle
Senghore, Madikay
Khandaker, Shadia
Xu, Rong
Bricio-Moreno, Laura
Yang, Marie
Dowson, Christopher G.
Everett, Dean B.
Neill, Daniel R.
Kadioglu, Aras
author_facet Jacques, Laura C.
Panagiotou, Stavros
Baltazar, Murielle
Senghore, Madikay
Khandaker, Shadia
Xu, Rong
Bricio-Moreno, Laura
Yang, Marie
Dowson, Christopher G.
Everett, Dean B.
Neill, Daniel R.
Kadioglu, Aras
author_sort Jacques, Laura C.
collection PubMed
description Streptococcus pneumoniae serotype 1 is the predominant cause of invasive pneumococcal disease in sub-Saharan Africa, but the mechanism behind its increased invasiveness is not well understood. Here, we use mouse models of lung infection to identify virulence factors associated with severe bacteraemic pneumonia during serotype-1 (ST217) infection. We use BALB/c mice, which are highly resistant to pneumococcal pneumonia when infected with other serotypes. However, we observe 100% mortality and high levels of bacteraemia within 24 hours when BALB/c mice are intranasally infected with ST217. Serotype 1 produces large quantities of pneumolysin, which is rapidly released due to high levels of bacterial autolysis. This leads to substantial levels of cellular cytotoxicity and breakdown of tight junctions between cells, allowing a route for rapid bacterial dissemination from the respiratory tract into the blood. Thus, our results offer an explanation for the increased invasiveness of serotype 1.
format Online
Article
Text
id pubmed-7170840
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-71708402020-04-23 Increased pathogenicity of pneumococcal serotype 1 is driven by rapid autolysis and release of pneumolysin Jacques, Laura C. Panagiotou, Stavros Baltazar, Murielle Senghore, Madikay Khandaker, Shadia Xu, Rong Bricio-Moreno, Laura Yang, Marie Dowson, Christopher G. Everett, Dean B. Neill, Daniel R. Kadioglu, Aras Nat Commun Article Streptococcus pneumoniae serotype 1 is the predominant cause of invasive pneumococcal disease in sub-Saharan Africa, but the mechanism behind its increased invasiveness is not well understood. Here, we use mouse models of lung infection to identify virulence factors associated with severe bacteraemic pneumonia during serotype-1 (ST217) infection. We use BALB/c mice, which are highly resistant to pneumococcal pneumonia when infected with other serotypes. However, we observe 100% mortality and high levels of bacteraemia within 24 hours when BALB/c mice are intranasally infected with ST217. Serotype 1 produces large quantities of pneumolysin, which is rapidly released due to high levels of bacterial autolysis. This leads to substantial levels of cellular cytotoxicity and breakdown of tight junctions between cells, allowing a route for rapid bacterial dissemination from the respiratory tract into the blood. Thus, our results offer an explanation for the increased invasiveness of serotype 1. Nature Publishing Group UK 2020-04-20 /pmc/articles/PMC7170840/ /pubmed/32312961 http://dx.doi.org/10.1038/s41467-020-15751-6 Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Jacques, Laura C.
Panagiotou, Stavros
Baltazar, Murielle
Senghore, Madikay
Khandaker, Shadia
Xu, Rong
Bricio-Moreno, Laura
Yang, Marie
Dowson, Christopher G.
Everett, Dean B.
Neill, Daniel R.
Kadioglu, Aras
Increased pathogenicity of pneumococcal serotype 1 is driven by rapid autolysis and release of pneumolysin
title Increased pathogenicity of pneumococcal serotype 1 is driven by rapid autolysis and release of pneumolysin
title_full Increased pathogenicity of pneumococcal serotype 1 is driven by rapid autolysis and release of pneumolysin
title_fullStr Increased pathogenicity of pneumococcal serotype 1 is driven by rapid autolysis and release of pneumolysin
title_full_unstemmed Increased pathogenicity of pneumococcal serotype 1 is driven by rapid autolysis and release of pneumolysin
title_short Increased pathogenicity of pneumococcal serotype 1 is driven by rapid autolysis and release of pneumolysin
title_sort increased pathogenicity of pneumococcal serotype 1 is driven by rapid autolysis and release of pneumolysin
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7170840/
https://www.ncbi.nlm.nih.gov/pubmed/32312961
http://dx.doi.org/10.1038/s41467-020-15751-6
work_keys_str_mv AT jacqueslaurac increasedpathogenicityofpneumococcalserotype1isdrivenbyrapidautolysisandreleaseofpneumolysin
AT panagiotoustavros increasedpathogenicityofpneumococcalserotype1isdrivenbyrapidautolysisandreleaseofpneumolysin
AT baltazarmurielle increasedpathogenicityofpneumococcalserotype1isdrivenbyrapidautolysisandreleaseofpneumolysin
AT senghoremadikay increasedpathogenicityofpneumococcalserotype1isdrivenbyrapidautolysisandreleaseofpneumolysin
AT khandakershadia increasedpathogenicityofpneumococcalserotype1isdrivenbyrapidautolysisandreleaseofpneumolysin
AT xurong increasedpathogenicityofpneumococcalserotype1isdrivenbyrapidautolysisandreleaseofpneumolysin
AT briciomorenolaura increasedpathogenicityofpneumococcalserotype1isdrivenbyrapidautolysisandreleaseofpneumolysin
AT yangmarie increasedpathogenicityofpneumococcalserotype1isdrivenbyrapidautolysisandreleaseofpneumolysin
AT dowsonchristopherg increasedpathogenicityofpneumococcalserotype1isdrivenbyrapidautolysisandreleaseofpneumolysin
AT everettdeanb increasedpathogenicityofpneumococcalserotype1isdrivenbyrapidautolysisandreleaseofpneumolysin
AT neilldanielr increasedpathogenicityofpneumococcalserotype1isdrivenbyrapidautolysisandreleaseofpneumolysin
AT kadiogluaras increasedpathogenicityofpneumococcalserotype1isdrivenbyrapidautolysisandreleaseofpneumolysin